LSUHSC research discovers new targets for treatment of invasive bre... ( New Orleans LA Research led by Sure...)

LSUHSC research discovers new targets for treatment of invasive breast cancer

Date:8/19/2009

New Orleans, LA Research led by Suresh Alahari, PhD, Associate Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, has shown for the first time that a tiny piece of RNA appears to play a major role in the development of invasive breast cancer and identified a gene that appears to inhibit invasive breast cancer. The research is published in the August 21, 2009 issue of the Journal of Biological Chemistry.

The LSUHSC researchers are the first to demonstrate that miR-27b, a novel microRNA, not only inactivates the ST14 gene which they found suppresses the growth of breast tumor cells, but also that miR-27b stimulates the breast cancer to invade other cells.

MicroRNAs are a new class of small, single-stranded RNA molecules which play an important regulatory role in cell biology. They bind to target genes and decrease their function. MicroRNAs may act as oncogenes (a gene that contributes to cancer development) or tumor suppressors.

In this study working with a line of human breast cancer cells, Dr. Alahari's team found that aggressively invasive breast tumor cells contain a large quantity of miR-27b molecules, while normal cells do not. Further analysis revealed that miR-27b increases during cancer progression, in direct proportion to the decrease in function of the ST14 gene. They found that miR-27b promotes cell growth and cell invasion, suggesting that miR-27b acts as a breast cancer oncogene. They also found that ST14 inhibits both cell growth and cell invasion, suggesting that ST14 is a breast cancer tumor suppressor gene and that it may also serve as a marker for the early detection of breast cancer.

According to the American Cancer Society, an estimated 192,370 new cases of invasive breast cancer are expected to occur among women in the US during 2009; about 1,910 new cases are expected in men. Excluding cancers of the skin, breast cancer is the most frequently diagnosed cancer in women. A
'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

1

GOOD

Page: 1 2
Related medicine news :

1. LSUHSC contributes to revealing targets to reduce racial disparity in prostate cancer deaths
2. LSUHSC research identifies enzyme that makes survival molecule for key vision cells
3. LSUHSC research finds single gene controls growth of some cancers
4. LSUHSC researchers first to document early signs for diabetes in kids as young as 7
5. LSUHSC dental researcher funded to develop better dental materials
6. LSUHSC research shows fish oil protects against diseases like Parkinsons
7. LSUHSC research may benefit diabetes by increasing understanding of how to control islet cell growth
8. LSUHSCs England leads development of new testing guidelines for common nerve disorder
9. LSUHSCs Dr. Xiao Cheng Wu co-authors annual report to the nation on cancer
10. LSUHSCs Fontham makes history
11. LSUHSC public health contributes to estimate of HPV-related cancers

Post Your Comments:

(Date:2/9/2010)... more weight than peers who tried lifestyle changes , , ... who received gastric banding surgery lost significantly more weight ... and exercise, Australian researchers report. , Their study included ... index (BMI) higher than 35 (statistical obesity begins at ... banding while the other half took part in a ...

(Date:2/9/2010)... more likely to insert them , , TUESDAY, Feb. 9 ... set up to make a profit are more likely ... despite evidence that the practice does not prolong life ... "Our results suggest that decisions about feeding tubes are ... decision-making process that really elicits and supports patient choice," ...

(Date:2/9/2010)... PAUL, Minn. , Feb. 9 /PRNewswire-USNewswire/ ... chronic obstructive pulmonary disease (COPD), is now being ... Public Health Tracking Program. The program focuses on ... that can be triggered or made worse ... outdoor air pollution — asthma, heart attacks and ...

(Date:2/9/2010)... the Heart with "The Heart-Smart Diabetes Kitchen" ... Show your love this Valentine,s ... the heart with the new cookbook "The Heart-Smart Diabetes ... Oil" by the American Diabetes Association (ADA) and CanolaInfo. ... or give the cookbook as a gift, you will ...

(Date:2/9/2010)... In conjunction with the 2010 Super Bowl, ... (LSI) sponsored the first-annual Gridiron Greats Night of Champions, a ... Mike Ditka and Jamie Foxx . Supported ... Greats is a non-profit organization that provides financial assistance and ... This year, Gridiron Greats recognized LSI at the event as ...

Breaking Medicine News(10 mins):Health News:Gastric Banding Most Effective for Obese Teens 2 Health News:Too Many With End-Stage Dementia Get Feeding Tubes 2 Health News:Too Many With End-Stage Dementia Get Feeding Tubes 3 Health News:Minnesota Department of Health Report: Nearly 6,000 Hospitalizations for COPD in 2007 2 Health News:Cook With Love This Valentine's Day With Heart-Smart Recipes 2 Health News:Cook With Love This Valentine's Day With Heart-Smart Recipes 3 Health News:Laser Spine Institute Honored at the Gridiron Greats Night of Champions 2

[0] Gastric Banding Most Effective for Obese Teens [0] Too Many With End-Stage Dementia Get Feeding Tubes [0] Minnesota Department of Health Report: Nearly 6,000 Hospitalizations for COPD in 2007 [0] Cook With Love This Valentine's Day With Heart-Smart Recipes [0] Laser Spine Institute Honored at the Gridiron Greats Night of Champions

... in New Television Ad, SACRAMENTO, Calif., Oct. 28 ... new television spot featuring Senator Diane Feinstein,who, speaking directly ... mistake for California. It,s about discrimination and we must,always ... to have the strong, trusted and independent voice of,Senator ...

... study found , , TUESDAY, Oct. 28 (HealthDay News) -- ... one-third lower for those taking statins than for those ... , While the findings are preliminary and offer hope, ... as infection fighters, experts said. , "I think we ...

... Complaint Alleges Defamation, Trade Libel and Intentional Interference with ... Prospective ... BPUR ) announced today that it had filed an ... co-authored an,article and several letters about Hemopure, hemoglobin glutamer-250,(bovine), Biopure,s ...

... Sales Grow 52% Worldwide, 24% in U.S. ... Cost Reduction Efforts Continue to Generate Results ... by 29%, Company Completes Clinical Data Step for Visian Toric ICL Application to ... FDA, ...

... worsens, research shows , , TUESDAY, Oct. 28 (HealthDay News) ... gum disease, a U.S. study finds. , Previous research ... a condition where chronic inflammation results in the separation ... support, and possible tooth loss. , In this new ...

... 28 Blue Mountain Quality,Resources, Inc. announced ... Regulatory Asset Manager(R) to satisfy their immediate ... their enterprise-wide,SAP(R) implementation., "Alexion is committed ... in,its manufacturing facilities and other operations," explains ...

Senator Dianne Feinstein Denounces Prop 8 Statins Reduced Death Risk From Pneumonia Biopure Sues National Institutes of Health Official STAAR Surgical Reports 33% Third Quarter Revenue Growth Rheumatoid Arthritis May Harm Gums Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Management Integrated with SAP(R)

(Date:2/8/2010)... 8 Cost reductions offset a recession-driven ... AHPI ) narrowly back into profitability in the second ... quarter ended December 31, 2009 declined almost ... the same quarter last year to $11.4 million ... sales were reduced even more sharply, from approximately ...

(Date:2/8/2010)... N.J. , Feb. 8 Savient ... the company will release financial results for the fourth ... market on Thursday, February 25, 2010 . ... Group Vice President and Chief Financial Officer, will host ... a.m. Eastern Time on February 26, 2010 ...

(Date:2/8/2010)... Hanger Orthopedic Group, Inc. (NYSE: HGR ) announced ... for the year ended December 31, 2009 , on ... to issue a press release announcing the results for the ... February 10, 2010 , after the close of the market. ... a.m., EST , on Thursday, February 11, 2010 . ...

Breaking Medicine Technology:Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 2 Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 3 Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 4 Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 5 Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 6 Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010 2 Hanger Orthopedic Group, Inc. Announces 2009 Year-End Earnings Release Conference Call 2 ReSearch Pharmaceutical Services Inc to Present at Jefferies 2010 Global Healthcare Conference 65027 1 ReSearch Pharmaceutical Services Inc to Present at Jefferies 2010 Global Healthcare Conference 65027 2 The Advisory Board Company Schedules Third Quarter Conference Call for February 4 2010 15383 1 The Advisory Board Company Schedules Third Quarter Conference Call for February 4 2010 15383 2 Clinical Data Presented at Asia PCR Sing LIVE Demonstrate Benefits of OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 in Challenging Patient 7462 1 Clinical Data Presented at Asia PCR Sing LIVE Demonstrate Benefits of OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 in Challenging Patient 7462 2 Clinical Data Presented at Asia PCR Sing LIVE Demonstrate Benefits of OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 in Challenging Patient 7462 3 Clinical Data Presented at Asia PCR Sing LIVE Demonstrate Benefits of OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 in Challenging Patient 7462 4

[0] Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions [0] Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010 [0] Hanger Orthopedic Group, Inc. Announces 2009 Year-End Earnings Release Conference Call

... 16 Anthera Pharmaceuticals,Inc., a privately held ... after completing its review,of safety and efficacy ... Board (DSMB) has recommended that Anthera,s Phase ... of the Modulation of,Phospholipase in Acute ChesT ...

... Treximet provided significantly more patients ... sumatriptan 85 mg, LONDON, April 15 GlaxoSmithKline (LSE: ... ) announced today that the FDA has,approved Treximet for the ... Treximet is the first and only migraine product,designed to target ...

Other Medicine Technology:DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease 2 Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 2 Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 3 Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 4 Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 5 Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 6 Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 7

DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine

... ELISA test for Clostridium difficile antigen that ... sensitivity. That means the laboratory can quickly, ... negatives - which can represent up to ... the organism - and be sure that ...

... test is a rapid immunoassay to detect Clostridium ... The test uses antibodies specific for toxins A ... sensitivity and >99% specificity compared to tissue culture. ... toxin B, the risk of false negative results ...

... autoimmune testing feature single-well ANA screen and ... reflex tests including dsDNA, and 6 individual ... (La), Scl-70 and Jo-1. In addition, our ... of products for Cardiolipins (IgA, IgG, IgM), ...

... for autoimmune testing feature single-well ANA screen ... specific reflex tests including dsDNA, and 6 ... SS-B (La), Scl-70 and Jo-1. In addition, ... line of products for Cardiolipins (IgA, IgG, ...

Medicine Products:

C. Diff-CHEK-30 TOX A/B QUIK CHEK Gliadin IgA II Cardiolipin IgG, A, M

LSUHSC research discovers new targets for treatment of invasive bre...( New Orleans LA Research led by Sure...),Health